Post by
Corvetteman on May 31, 2022 11:45am
In heavy
I for one am sticking by this company. The covid years have openned posibilities for RDT. It takes time to be taken seriously with the big pharma boys. This delivery system works and I say that it will be successful in the near future. $2.50 to $5.00 isn't out of the relm of posibilities. Try to find another product that has this kind of bright future. I'm in for the long run.
Comment by
Luckierjack2 on Jun 01, 2022 1:22pm
Corvette man, Good luck with your DOSE. I mean that truly. The last financials indicated they are out of money and the convertible debt issue is desperation measure that may or may not fly. The $0.40 conversion price is not attractive to investors. JMHO LJ
Comment by
Corvetteman on Jun 28, 2022 8:20am
I see where you are coming from Jack. I beleive in this product, and other countries do as well. Yes the financial management has been screwing up but the product is a solid contender. It will in my mind make a breakthough.
Comment by
Luckierjack2 on Jun 22, 2022 6:12pm
Two months late in filing financial statements. Very bad form from management. Barf Glad I am out as this might get halted again.